New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case

Loading player...
Flagship Asset Management fund manager, Philip Short
New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case
24 Jun 2024 9AM English South Africa Business

Other recent episodes

The Brandfather

The Brandfather Jeremy Sampson, MD of Brand Finance Africa
11 Sep 9AM 16 min